Notably, miR-146a is a potential therapeutic target for COPD, and the rs2910164 polymorphism in it is associated with a decrease in miR-146a levels and a rise in cyclooxygenase 2 (COX2) in smokers with COPD [81]. The gene discussed is PTGS2; the disease is chronic obstructive pulmonary disease.